Replies to post #168934 on Biotech Values

[mcbio]

TGTX

You may not like to hear this but I own it also. I added yesterday.

Hey, the more, the merrier. ; )

The CD 20 drug has had some great data.

The drug clearly seems to have activity given CRs in Rituxan-refractory patients. That should have at least some value IMO, even if we assign no value to the PI3K-delta (let's see what ASH update brings here).

The company raised 30 million dollars at 6.05 three months ago. The drop doesn't make sense in this bull market.

I agree. I can hold indefinitely so no big deal to me. If weakness persists, I may consider adding at some point. My position is so small, it's going to take at least a triple for this to be anything meaningful for me.